How Bad Is Prednisone?

Understanding the Burden of Corticosteroid Therapy in IgA Nephropathy Treatment

Prednisone has long been a cornerstone in the treatment of inflammatory conditions, including IgA nephropathy. While its effectiveness in suppressing the immune response is well-documented, a growing body of research highlights the significant burden it can place on patients. A recent comprehensive study offers fresh insights into the pros and cons of using prednisone in this context, calling for a more cautious and strategic approach.

Watch now!

What Is Prednisone and Why Is It Used?

Prednisone is a synthetic corticosteroid that mimics cortisol, a hormone produced naturally by the adrenal glands. It is commonly prescribed for autoimmune and inflammatory conditions due to its powerful anti-inflammatory and immunosuppressive effects.

In IgA nephropathy—a kidney disorder marked by the buildup of immunoglobulin A (IgA) in the glomeruli—prednisone is often used to reduce kidney inflammation and slow disease progression. However, the same mechanisms that make it effective also contribute to a broad spectrum of potential side effects.

Key Findings from the Study

A large-scale analysis involving data from over 64 clinical trials and thousands of patients revealed several concerning trends in prednisone usage for IgA nephropathy:

• Duration of Treatment: About 59% of patients were on prednisone for 8 to 24 months.
• Correlation with Side Effects: Longer treatment durations were clearly linked to more severe side effects.

These findings suggest that while prednisone can be beneficial, prolonged use significantly raises the risk of complications.

Common and Concerning Prednisone Side Effects

The study highlighted a wide range of prednisone-related side effects—some of which were particularly alarming:

• Metabolic Issues: Weight gain, high cholesterol, and diabetes (affecting 3–5% of patients).
• Cushing’s Syndrome: Symptoms include a round “moon” face, abdominal obesity, and muscle wasting.
• Eye and Bone Problems: Increased risk of cataracts, osteoporosis, and joint issues.
• Immune Suppression: Even at low doses, prednisone raises the risk of infections.

In total, up to 150 different side effects have been associated with prednisone, underlining the need for caution and monitoring.

Promising Alternative Treatment for IgA Nephropathy

Given the risks, many experts advocate for newer, more targeted treatment strategies:

• Targeted Steroid Therapy: Budesonide, which is released directly in the gut, limits systemic exposure and reduces side effects.
• Steroid-Free Options: Emerging drugs like sparsentan and iptacopan are showing promise, especially for those with less aggressive forms of IgA nephropathy.
• Supportive Therapies: Blood pressure medications such as ACE inhibitors and ARBs can help protect kidney function without relying on steroids.

These alternatives aim to balance efficacy with a reduced risk of long-term harm.

A Strategic, Patient-Centered Approach

The study recommends that prednisone be reserved for patients at high risk of progression to end-stage kidney disease, and even then, it should be prescribed for the shortest duration possible. Shared decision-making with healthcare providers is essential in weighing the benefits against the risks.

To support patients, I created the “Prednisone Checklist”. This resource offers proactive strategies for managing side effects and improving quality of life during treatment.

Final Thoughts

Prednisone remains a powerful tool in the treatment of IgA nephropathy—but one that comes with considerable risks. This latest research reinforces the need for thoughtful prescribing, ongoing patient education, and the exploration of safer alternatives.

With careful monitoring and access to tools like the Prednisone Checklist, patients can better manage their treatment journey and achieve more favorable long-term outcomes.